Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro M Enriquez-Navas

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cancer Research|November 4, 2015
Application of Evolutionary Principles to Cancer TherapyPedro M Enriquez-Navas, Jonathan W Wojtkowiak, Robert A Gatenby
Immunology|February 28, 2018
Hypoxia and acidosis: immune suppressors and therapeutic targetsSultan Damgaci, Arig Ibrahim-Hashim, Pedro M Enriquez-Navas, et al.
Cancer Research|February 1, 2018
Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer TherapiesJill A Gallaher, Pedro M Enriquez-Navas, Kimberly A Luddy, et al.
Cancer Medicine|May 31, 2017
Tris-base buffer: a promising new inhibitor for cancer progression and metastasisArig Ibrahim-Hashim, Dominique Abrahams, Pedro M Enriquez-Navas, et al.
Science Translational Medicine|February 26, 2016
Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancerPedro M Enriquez-Navas, Yoonseok Kam, Tuhin Das, et al.
Cancer Research|March 3, 2017
Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral EvolutionArig Ibrahim-Hashim, Mark Robertson-Tessi, Pedro M Enriquez-Navas, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cancer Research|November 4, 2015
Application of Evolutionary Principles to Cancer TherapyPedro M Enriquez-Navas, Jonathan W Wojtkowiak, Robert A Gatenby
Immunology|February 28, 2018
Hypoxia and acidosis: immune suppressors and therapeutic targetsSultan Damgaci, Arig Ibrahim-Hashim, Pedro M Enriquez-Navas, et al.
Cancer Research|February 1, 2018
Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer TherapiesJill A Gallaher, Pedro M Enriquez-Navas, Kimberly A Luddy, et al.
Cancer Medicine|May 31, 2017
Tris-base buffer: a promising new inhibitor for cancer progression and metastasisArig Ibrahim-Hashim, Dominique Abrahams, Pedro M Enriquez-Navas, et al.
Science Translational Medicine|February 26, 2016
Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancerPedro M Enriquez-Navas, Yoonseok Kam, Tuhin Das, et al.
Cancer Research|March 3, 2017
Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral EvolutionArig Ibrahim-Hashim, Mark Robertson-Tessi, Pedro M Enriquez-Navas, et al.
Pageof 1